Sat10252014

Last updateFri, 24 Oct 2014 11pm

Back You are here: Home News News ETMC first to test new treatment for blocked heart vessels in state

News

ETMC first to test new treatment for blocked heart vessels in state

East Texas cardiologists are the first in Texas to implant an investigational bioresorbable vascular scaffold - similar to a stent except it eventually dissolves - for patients with heart disease as part of a national clinical trial.

Absorb, manufactured by the healthcare company Abbott, is a small mesh tube that is designed to open a blocked heart vessel and restore blood flow to the heart. Unlike a metallic stent that remains permanently in the body, Absorb is referred to as a scaffold to indicate that it is a temporary structure. For more details about the new implant see the July 11 edition of the Mount Vernon Optic-Herald.